Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04426162 · ClinicalTrials.gov registry record · NA

Effects of Memory Boot Camp on Brain Function in Adults With Symptoms of Mild Cognitive Impairment (MCI)

A NA study of Mild Cognitive Impairment, sponsored by Neurocore.

Completed
Registry status
NA
Development phase
76
Enrollment target
3
Study locations

NCT04426162 is a NA study of Mild Cognitive Impairment that has completed, run by Neurocore. The registered enrollment target is 76 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (94% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04426162, a NA study of Mild Cognitive Impairment, has completed, sponsored by Neurocore.

COMPLETED
Registry status
NA
Development phase
76 participants
Enrollment target
3
Study locations

Study Summary

This is a prospective controlled clinical trial to determine the effects of a 12-week Memory Boot Camp (MBC) program on cognitive function in older adults with symptoms of Mild Cognitive Impairment.

Conditions Studied

Interventions

  • OTHER Multi-domain Intervention

Study Locations (3)

Florida

  • Neurocore Brain Performance Center - Boca Raton
  • Neurocore Brain Performance Center - Palm Beach Gardens

Michigan

  • Neurocore Brain Performance Center - Grandville

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2017-10-05
Est. Completion 2019-04-24
Phase NA

Sponsor

Neurocore

1 total trials

What the Registry Record Tells You About NCT04426162

The ClinicalTrials.gov registry entry for NCT04426162 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (94% lower). The listed sponsor is Neurocore, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which Multi-domain Intervention is the first listed.

NCT04426162 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Florida, Michigan.

Frequently Asked Questions

What is clinical trial NCT04426162 about?

NCT04426162 is a clinical study titled "Effects of Memory Boot Camp on Brain Function in Adults With Symptoms of Mild Cognitive Impairment (MCI)". This is a prospective controlled clinical trial to determine the effects of a 12-week Memory Boot Camp (MBC) program on cognitive function in older adults with symptoms of Mild Cognitive Impairment.

What is the current status of trial NCT04426162?

This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2017-10-05. Estimated completion is 2019-04-24.

What conditions does trial NCT04426162 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment.

What interventions are being tested in trial NCT04426162?

The interventions under investigation include: Multi-domain Intervention (OTHER).

Who is sponsoring clinical trial NCT04426162?

This trial is sponsored by Neurocore, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04426162 being conducted?

This trial has 3 study locations across Florida, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.